A nod to immunomod with fingolimod

In general, your immune system does a truly amazing job of keeping you healthy and the dangerous pathogenic world around us at bay. Trillions of cells constantly monitor for viruses and other illness-causing agents and ruthlessly disposing of any that they actually find. But sometimes your immune system can get a little carried away with this task and researchers have developed medications that turn down the volume of immune system activity. Recently, researchers have reported new data that points towards a particular class of immune cells (lymphocytes) in Parkinson’s, and they have also identified a pathway that could be targeted therapeutically. In today’s post, we will discuss what lymphocytes are and consider new data highlighting an immunomodulation treatment avenue that could be explored in Parkinson’s.